Certain Recombinantly Produced Human Growth Hormones; Notice of Commission Determination Not To Review an Initial Determination Granting Complainant's Motion To Amend the Complaint and Notice of Investigation To Withdraw a Patent Claim

Riepilogo

Notice is hereby given that the U.S. International Trade Commission has determined not to review the presiding administrative law judge's (ALJ's) initial determination (ID) in the above-captioned investigation granting complainant Genentech, Inc.'s motion to amend the complaint and notice of investigation by withdrawing claim 38 of U.S. Letters Patent 5,221,619 from the investigation.